Prescription drug · BLA
Ebanga (Ansuvimab) NDC 71655-578
Ansuvimab 400 mg/8mL · Injection, Powder, Lyophilized, For solution · Intravenous · Emergent BioDefense Operations Lansing LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71655-578-03 | 7165505780371655057803 | 1 CARTON in 1 BOX (71655-578-03) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)Marketed from Dec 21, 2020 | |
| 71655-578-04 | 7165505780471655057804 | 4 CARTON in 1 BOX (71655-578-04) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)Marketed from Dec 21, 2020 | |
| 71655-578-08 | 7165505780871655057808 | 8 CARTON in 1 BOX (71655-578-08) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)Marketed from Dec 21, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ebanga
- Generic name (nonproprietary)
- ansuvimab
- Active ingredients
- Ansuvimab — 400 mg/8mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous
- Labeler
- Emergent BioDefense Operations Lansing LLCNDC labeler code 71655
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761172
- Marketing start
- Listing expires
- Other FDA classes
- Zaire Ebolavirus Glycoprotein-directed Antibody Interactions (Mechanism)
- Identifiers
- Product ID 71655-578_58f2d4af-2a78-c5f5-e063-6294a90a36bbSPL ID 58f2d4af-2a78-c5f5-e063-6294a90a36bbSPL set ID de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5RxCUI 2472156, 2472161UNII TG8IQ19NG2
- Pharmacologic class
- Zaire Ebolavirus Glycoprotein-directed Antibody
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N471655057803followed by a unit qualifier and the quantityPackage 71655-0578-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
EBANGA is indicated for the treatment of infection caused by Orthoebolavirus zairense (formerly Zaire ebolavirus) in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Orthoebolavirus zairense infection [see Dosage and Administration (2.2) and Clinical Studies (14) ]. EBANGA (ansuvimab-zykl) is an Orthoebolavirus zairense glycoprotein (EBOV GP)-directed human monoclonal antibody indicated for the treatment of infection caused by Orthoebolavirus zairense in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Orthoebolavirus zairense infection. ( 1 ) Limitation of Use The efficacy of EBANGA has not been establis…
Excerpt only. Read the full label for complete information.
About NDC 71655-578
- What is NDC 71655-578?
- 71655-578 is the product NDC for Ebanga (ansuvimab), Ansuvimab 400 mg/8mL injection, powder, lyophilized, for solution, listed with the FDA by Emergent BioDefense Operations Lansing LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ebanga (Ansuvimab).
- What is the active ingredient?
- Ansuvimab.
- Who is the labeler?
- Emergent BioDefense Operations Lansing LLC, NDC labeler code 71655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ebanga?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.